Extended storage of buffy coat platelet concentrates in plasma or a platelet additive solution. 2014

Sherrill J Slichter, and Doug Bolgiano, and Jill Corson, and Mary Kay Jones, and Todd Christoffel, and S Lawrence Bailey, and Esther Pellham
Puget Sound Blood Center, Seattle, Washington; University of Washington School of Medicine, Seattle, Washington.

BACKGROUND Platelet (PLT) concentrates (PCs) prepared from whole blood in the United States are made using the PLT-rich plasma method. The PCs must be made within 8 hours of blood collection and stored for only 5 days. In Europe and Canada, PCs are made using the buffy coat (BC) method from whole blood held overnight at 22 °C and storage times may be up to 7 days. Our studies were designed to determine how long BC PLTs can be stored in plasma or Plasmalyte while meeting the FDA's poststorage viability criteria. METHODS Normal subjects donated whole blood that was stored at 22 °C for 22 ± 2 hours before preparation of BC PLTs. PLTs were stored for 5 to 8 days in either plasma or Plasmalyte concentrations of 65 or 80%. Radiolabeled autologous stored versus fresh PLT recoveries and survivals were assessed as well as poststorage in vitro assays. RESULTS BC PLTs stored in either plasma or 65% Plasmalyte met FDA poststorage PLT recovery criteria for 7 days but survivals for only 6 days, while storage in 80% Plasmalyte gave very poor results. Both stored PLT recoveries and survivals correlated with the same donor's fresh results, but the correlation was much stronger between recoveries than survivals. In vitro measures of extent of shape change, morphology score, and pH best predicted poststorage PLT recoveries, while annexin V binding best predicted PLT survivals. CONCLUSIONS BC PLTs stored in either plasma or 65% Plasmalyte meet FDA's poststorage viability criteria for 6 days.

UI MeSH Term Description Entries
D001792 Blood Platelets Non-nucleated disk-shaped cells formed in the megakaryocyte and found in the blood of all mammals. They are mainly involved in blood coagulation. Platelets,Thrombocytes,Blood Platelet,Platelet,Platelet, Blood,Platelets, Blood,Thrombocyte
D001793 Blood Preservation The process by which blood or its components are kept viable outside of the organism from which they are derived (i.e., kept from decay by means of a chemical agent, cooling, or a fluid substitute that mimics the natural state within the organism). Blood Preservations,Preservation, Blood,Preservations, Blood
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D053657 Platelet-Rich Plasma A preparation consisting of PLATELETS concentrated in a limited volume of PLASMA. This is used in various surgical tissue regeneration procedures where the GROWTH FACTORS in the platelets enhance wound healing and regeneration. Plasma, Platelet-Rich,Platelet Rich Plasma

Related Publications

Sherrill J Slichter, and Doug Bolgiano, and Jill Corson, and Mary Kay Jones, and Todd Christoffel, and S Lawrence Bailey, and Esther Pellham
July 2005, Vox sanguinis,
Sherrill J Slichter, and Doug Bolgiano, and Jill Corson, and Mary Kay Jones, and Todd Christoffel, and S Lawrence Bailey, and Esther Pellham
May 2008, Vox sanguinis,
Sherrill J Slichter, and Doug Bolgiano, and Jill Corson, and Mary Kay Jones, and Todd Christoffel, and S Lawrence Bailey, and Esther Pellham
April 2011, Cryobiology,
Sherrill J Slichter, and Doug Bolgiano, and Jill Corson, and Mary Kay Jones, and Todd Christoffel, and S Lawrence Bailey, and Esther Pellham
May 2008, Transfusion,
Sherrill J Slichter, and Doug Bolgiano, and Jill Corson, and Mary Kay Jones, and Todd Christoffel, and S Lawrence Bailey, and Esther Pellham
August 2009, Vox sanguinis,
Sherrill J Slichter, and Doug Bolgiano, and Jill Corson, and Mary Kay Jones, and Todd Christoffel, and S Lawrence Bailey, and Esther Pellham
October 2012, Transfusion,
Sherrill J Slichter, and Doug Bolgiano, and Jill Corson, and Mary Kay Jones, and Todd Christoffel, and S Lawrence Bailey, and Esther Pellham
May 2018, Blood transfusion = Trasfusione del sangue,
Sherrill J Slichter, and Doug Bolgiano, and Jill Corson, and Mary Kay Jones, and Todd Christoffel, and S Lawrence Bailey, and Esther Pellham
June 1992, Infusionstherapie und Transfusionsmedizin,
Sherrill J Slichter, and Doug Bolgiano, and Jill Corson, and Mary Kay Jones, and Todd Christoffel, and S Lawrence Bailey, and Esther Pellham
December 2017, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis,
Sherrill J Slichter, and Doug Bolgiano, and Jill Corson, and Mary Kay Jones, and Todd Christoffel, and S Lawrence Bailey, and Esther Pellham
August 2003, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis,
Copied contents to your clipboard!